FDA Alerts

MRI
MRI
FDA Issues Warning for Patients with Implantable Infusion Pumps Undergoing MRIs
01/12/2017
The FDA has issued a warning of potential injury and death associated with the use of implantable infusion pumps in the magnetic resonance environment.
01/12/2017
opioid
opioid
FDA Approves New Abuse-Deterrent Opioid
01/10/2017
The FDA has approved a long-acting opioid painkiller designed to be difficult to crush, manipulate, and abuse.
01/10/2017
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
Smoking cessation
Smoking cessation
FDA Removes Black Box Warning From Smoking Cessation Drug
12/19/2016
Based on the results of a recent clinical trial, the FDA has decided to remove its black box warning from the label of Chantix (varenicline).
12/19/2016
FDA
FDA
FDA: Use of General Anesthetics, Sedatives May Harm Young Children
12/16/2016
Children’s brain development may be adversely affected by the use of general anesthetic and sedation drugs, the FDA said in a warning statement.
12/16/2016
Atopic Dermatitis
Atopic Dermatitis
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/14/2016
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
12/14/2016
FDA
FDA
FDA Approves New Combination Drug for Type 2 Diabetes
12/13/2016
The FDA has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for the treatment of adults with type 2 diabetes.
12/13/2016
FDA Alerts
FDA Alerts
FDA Approves New Combination Drug for Type 2 Diabetes
12/13/2016
The FDA has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for the treatment of adults with type 2 diabetes.
12/13/2016
Diabetes Q&A
Diabetes Q&A
FDA Approves New Indication for Empagliflozin
12/02/2016
The FDA has approved Jardiance (empagliflozin) for the reduction of risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease.
12/02/2016